tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

FATE Stock Latest News

Hold Rating for Fate Therapeutics Amid Promising FT819 Developments and Ongoing Uncertainties
RatingsHold Rating for Fate Therapeutics Amid Promising FT819 Developments and Ongoing Uncertainties
1M ago
FATE
Fate Therapeutics price target lowered to $2.50 from $3 at BofA
PremiumThe Fly
Fate Therapeutics price target lowered to $2.50 from $3 at BofA
1M ago
FATE
Optimistic Outlook for Fate Therapeutics’ FT819 in Cell-Therapy Space Amid Promising Phase 1 Results
PremiumRatings
Optimistic Outlook for Fate Therapeutics’ FT819 in Cell-Therapy Space Amid Promising Phase 1 Results
1M ago
FATE
Fate Therapeutics Inc. Faces Global Expansion Challenges Amid Political and Economic Uncertainties
PremiumCompany Announcements
Fate Therapeutics Inc. Faces Global Expansion Challenges Amid Political and Economic Uncertainties
1M ago
FATE
Cautious Optimism: Hold Rating for Fate Therapeutics Amid Early-Stage Progress and Market Uncertainties
PremiumRatings
Cautious Optimism: Hold Rating for Fate Therapeutics Amid Early-Stage Progress and Market Uncertainties
1M ago
FATE
Hold Rating for Fate Therapeutics Amid Early-Stage Pipeline Uncertainty and Cautious Cash Position
PremiumRatingsHold Rating for Fate Therapeutics Amid Early-Stage Pipeline Uncertainty and Cautious Cash Position
1M ago
FATE
Fate Therapeutics price target lowered to $3 from $5 at Stifel
Premium
The Fly
Fate Therapeutics price target lowered to $3 from $5 at Stifel
1M ago
FATE
Fate Therapeutics price target lowered to $4 from $5 at Wells Fargo
Premium
The Fly
Fate Therapeutics price target lowered to $4 from $5 at Wells Fargo
1M ago
FATE
Cautious Outlook on Fate Therapeutics Amid FT819 Program Developments and Financial Uncertainties
PremiumRatings
Cautious Outlook on Fate Therapeutics Amid FT819 Program Developments and Financial Uncertainties
1M ago
FATE
Fate Therapeutics Advances CAR T-cell Programs Amid Financial Losses
PremiumCompany Announcements
Fate Therapeutics Advances CAR T-cell Programs Amid Financial Losses
1M ago
FATE
Fate Therapeutics reports Q4 EPS (44c), consensus (42c)
PremiumThe Fly
Fate Therapeutics reports Q4 EPS (44c), consensus (42c)
1M ago
FATE
FATE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
FATE Earnings this Week: How Will it Perform?
1M ago
FATE
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
ADTX
ARDX
Fate Therapeutics Announces Executive Leadership Transition
Premium
Company Announcements
Fate Therapeutics Announces Executive Leadership Transition
3M ago
8K
FATE
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
FATE
OTLK
Fate Therapeutics presents new data from FT819 study
PremiumThe Fly
Fate Therapeutics presents new data from FT819 study
4M ago
FATE
Fate Therapeutics Announces Leadership Transition for 2025
PremiumCompany Announcements
Fate Therapeutics Announces Leadership Transition for 2025
4M ago
8K
FATE
Fate Therapeutics CEO Wolchko to retire
PremiumThe Fly
Fate Therapeutics CEO Wolchko to retire
4M ago
FATE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
PLX
ACRS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
PLX
ACRS
Fate upgraded to Neutral at BofA after FT819 achieves DORIS remission
Premium
The Fly
Fate upgraded to Neutral at BofA after FT819 achieves DORIS remission
5M ago
FATE
Fate Therapeutics upgraded to Neutral from Underperform at BofA
Premium
The Fly
Fate Therapeutics upgraded to Neutral from Underperform at BofA
5M ago
FATE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >